News | Radiation Oncology | May 31, 2023

Elekta ONE, a comprehensive suite of end-to-end applications, offers clinicians more automation, more mobility and more time to spend with patients

Elekta ONE, a comprehensive suite of end-to-end applications, offers clinicians more automation, more mobility and more time to spend with patients

May 31, 2023 — Elekta announced the launch of the first phase of Elekta ONE*, its most comprehensive and advanced software portfolio for oncology departments and clinics, including radiation therapy planning, comprehensive treatment management, and delivery. It brings all Elekta software products, solutions and services under one umbrella providing all users with one unified software experience. 

Previously, many cancer clinics have wrestled with stand-alone, closed systems, each with a different purpose. The result has been an unfavorable user experience and steep learning curve, adding pressure to an already strained resource: the clinical team. Elekta ONE aims to improve efficiency in the clinic – by as much as 50 percent**, eventually – through smarter workflows, increased automation, and by learning from every patient treated. Its workflow-driven approach and deep integration between applications allows information to flow freely, giving clinicians a seamless user experience. 

Elekta ONE provides an intuitive, robust, and fast auto planning solution, allowing the clinical team to make faster decisions. In addition, it is the first commercially available system to feature proton therapy functionalities such as dynamic arc planning and robust linear energy transfer (LET) optimization. 

Gustaf Salford, Elekta’s CEO, says: “Elekta ONE is an integral part of our Access 2025 strategy and our vision of a world where everyone has access to the best cancer care. Combining personalized precision and integrated informatics in a solution that enables elevated productivity, ONE addresses the major clinical and operational pressures facing oncology today and in the future.”  

With more automation and integration – along with easier, faster, and more secured access to data and tools – clinicians are now able to provide more personalized treatments for their patients, with less effort. 

Elekta ONE was launched at the European Society for Radiotherapy and Oncology(ESTRO) annual meeting in Vienna.  

For more information: www.elekta.com/ONE
 
*Not available in all markets.
**Source: Elekta maintains data internally. 


Related Content

News | Radiology Imaging

Nov. 13, 2025 — Medical imaging AI company Avicenna.AI has launched AVI, a new platform that delivers AI results ...

Time November 13, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Artificial Intelligence

Nov. 6 — 2025, Gradient Health and DataFirst have announced a strategic partnership designed to bridge the gap between ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Teleradiology

Nov. 4, 2025 — Virtual Radiologic (vRad) recently announced the successful commercialization of The vRad Platform — a ...

Time November 10, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Subscribe Now